Immune correlates of clinical outcome in melanoma.

about

Immune correlates of clinical outcome in melanoma.

Item

http://www.wikidata.org/entity/Q48257119

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Immune correlates of clinical outcome in melanoma.

@en

Immune correlates of clinical outcome in melanoma.

@nl

type

Item

label

Immune correlates of clinical outcome in melanoma.

@en

Immune correlates of clinical outcome in melanoma.

@nl

prefLabel

Immune correlates of clinical outcome in melanoma.

@en

Immune correlates of clinical outcome in melanoma.

@nl

P1476

Immune correlates of clinical outcome in melanoma.

@en

P2860

Ipilimumab: an anti-CTLA-4 antibody for metastatic melanoma

Cancer immunotherapy: how low-level ionizing radiation can play a key role.

Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors.

Current management of metastatic breast cancer.

Immunological factors which influence response to immunotherapy in malignant melanoma.

T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression

Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy.

Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer

Combination immunotherapy: a road map.

Targeting of cancer neoantigens with donor-derived T cell receptor repertoires.

P31

scholarly article

P356

10.1111/IMM.12870

http://www.w3.org/2001/XMLSchema#string

P50

Graham Pawelec

P577

2017-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29164593

http://www.w3.org/2001/XMLSchema#string

P932

5838413

http://www.w3.org/2001/XMLSchema#string